Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

High avidity HSV-1 antibodies correlate with absence of amnestic Mild Cognitive Impairment conversion to Alzheimer's disease.

Agostini S, Mancuso R, Baglio F, Cabinio M, Hernis A, Costa AS, Calabrese E, Nemni R, Clerici M.

Brain Behav Immun. 2016 Nov;58:254-260. doi: 10.1016/j.bbi.2016.07.153. Epub 2016 Jul 25.

PMID:
27470229
2.

Increase in the IgG avidity index due to herpes simplex virus type 1 reactivation and its relationship with cognitive function in amnestic mild cognitive impairment and Alzheimer's disease.

Kobayashi N, Nagata T, Shinagawa S, Oka N, Shimada K, Shimizu A, Tatebayashi Y, Yamada H, Nakayama K, Kondo K.

Biochem Biophys Res Commun. 2013 Jan 18;430(3):907-11. doi: 10.1016/j.bbrc.2012.12.054. Epub 2012 Dec 19. Erratum in: Biochem Biophys Res Commun. 2014 Jul 18;450(1):925.

PMID:
23261465
3.

Relationship between herpes simplex virus-1-specific antibody titers and cortical brain damage in Alzheimer's disease and amnestic mild cognitive impairment.

Mancuso R, Baglio F, Agostini S, Cabinio M, Laganà MM, Hernis A, Margaritella N, Guerini FR, Zanzottera M, Nemni R, Clerici M.

Front Aging Neurosci. 2014 Oct 15;6:285. doi: 10.3389/fnagi.2014.00285. eCollection 2014.

4.

Lack of evidence for a role of HHV-6 in the pathogenesis of Alzheimer's disease.

Agostini S, Mancuso R, Baglio F, Cabinio M, Hernis A, Guerini FR, Calabrese E, Nemni R, Clerici M.

J Alzheimers Dis. 2016;49(1):229-35. doi: 10.3233/JAD-150464.

PMID:
26444787
5.
6.

The Uncinate Fasciculus as a Predictor of Conversion from Amnestic Mild Cognitive Impairment to Alzheimer Disease.

Hiyoshi-Taniguchi K, Oishi N, Namiki C, Miyata J, Murai T, Cichocki A, Fukuyama H.

J Neuroimaging. 2015 Sep-Oct;25(5):748-53. doi: 10.1111/jon.12196. Epub 2014 Dec 10.

PMID:
25491469
7.

Modulation of Immune Responses to Herpes Simplex Virus Type 1 by IFNL3 and IRF7 Polymorphisms: A Study in Alzheimer's Disease.

Costa AS, Agostini S, Guerini FR, Mancuso R, Zanzottera M, Ripamonti E, Racca V, Nemni R, Clerici M.

J Alzheimers Dis. 2017;60(3):1055-1063. doi: 10.3233/JAD-170520.

PMID:
28984602
8.

Increased Serum miR-206 Level Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Follow-up Study.

Xie B, Liu Z, Jiang L, Liu W, Song M, Zhang Q, Zhang R, Cui D, Wang X, Xu S.

J Alzheimers Dis. 2017;55(2):509-520.

PMID:
27662297
9.

Enriching amnestic mild cognitive impairment populations for clinical trials: optimal combination of biomarkers to predict conversion to dementia.

Yu P, Dean RA, Hall SD, Qi Y, Sethuraman G, Willis BA, Siemers ER, Martenyi F, Tauscher JT, Schwarz AJ.

J Alzheimers Dis. 2012;32(2):373-85. doi: 10.3233/JAD-2012-120832.

PMID:
22796873
10.

Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease.

Mah L, Binns MA, Steffens DC; Alzheimer's Disease Neuroimaging Initiative.

Am J Geriatr Psychiatry. 2015 May;23(5):466-76. doi: 10.1016/j.jagp.2014.10.005. Epub 2014 Oct 29.

11.

MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment.

Whitwell JL, Shiung MM, Przybelski SA, Weigand SD, Knopman DS, Boeve BF, Petersen RC, Jack CR Jr.

Neurology. 2008 Feb 12;70(7):512-20. Epub 2007 Sep 26.

12.

Elevated Epstein-Barr Virus Antibody Level is Associated with Cognitive Decline in the Korean Elderly.

Shim SM, Cheon HS, Jo C, Koh YH, Song J, Jeon JP.

J Alzheimers Dis. 2017;55(1):293-301.

PMID:
27589534
13.

A diffusion tensor MRI study of patients with MCI and AD with a 2-year clinical follow-up.

Scola E, Bozzali M, Agosta F, Magnani G, Franceschi M, Sormani MP, Cercignani M, Pagani E, Falautano M, Filippi M, Falini A.

J Neurol Neurosurg Psychiatry. 2010 Jul;81(7):798-805. doi: 10.1136/jnnp.2009.189639. Epub 2010 Apr 14.

PMID:
20392973
14.

Microstructural white matter changes in cognitively normal individuals at risk of amnestic MCI.

Zhuang L, Sachdev PS, Trollor JN, Kochan NA, Reppermund S, Brodaty H, Wen W.

Neurology. 2012 Aug 21;79(8):748-54. doi: 10.1212/WNL.0b013e3182661f4d. Epub 2012 Jul 25.

PMID:
22843270
15.

Diffusion tensor imaging measures of normal appearing white matter in patients who are aging, or have amnestic mild cognitive impairment, or Alzheimer's disease.

Wang JH, Lv PY, Wang HB, Li ZL, Li N, Sun ZY, Zhao BH, Huang Y.

J Clin Neurosci. 2013 Aug;20(8):1089-94. doi: 10.1016/j.jocn.2012.09.025. Epub 2013 Jun 17.

PMID:
23787190
16.

Titers of herpes simplex virus type 1 antibodies positively correlate with grey matter volumes in Alzheimer's disease.

Mancuso R, Baglio F, Cabinio M, Calabrese E, Hernis A, Nemni R, Clerici M.

J Alzheimers Dis. 2014;38(4):741-5. doi: 10.3233/JAD-130977.

PMID:
24072067
17.

Predicting the conversion of mild cognitive impairment to Alzheimer's disease based on the volumetric measurements of the selected brain structures in magnetic resonance imaging.

Nesteruk M, Nesteruk T, Styczyńska M, Barczak A, Mandecka M, Walecki J, Barcikowska-Kotowicz M.

Neurol Neurochir Pol. 2015;49(6):349-53. doi: 10.1016/j.pjnns.2015.09.003. Epub 2015 Sep 15.

PMID:
26652867
18.

Grey-matter volume as a potential feature for the classification of Alzheimer's disease and mild cognitive impairment: an exploratory study.

Guo Y, Zhang Z, Zhou B, Wang P, Yao H, Yuan M, An N, Dai H, Wang L, Zhang X, Liu Y.

Neurosci Bull. 2014 Jun;30(3):477-89. doi: 10.1007/s12264-013-1432-x. Epub 2014 Apr 23.

19.

Multi-modal MRI analysis with disease-specific spatial filtering: initial testing to predict mild cognitive impairment patients who convert to Alzheimer's disease.

Oishi K, Akhter K, Mielke M, Ceritoglu C, Zhang J, Jiang H, Li X, Younes L, Miller MI, van Zijl PC, Albert M, Lyketsos CG, Mori S.

Front Neurol. 2011 Aug 24;2:54. doi: 10.3389/fneur.2011.00054. eCollection 2011.

20.

[Prediction of conversion from amnestic mild cognitive impairment to Alzheimer's disease using proton magnetic resonance spectroscopy].

Watanabe T, Shiino A, Akiguchi I.

Rinsho Shinkeigaku. 2015;55(10):709-15. doi: 10.5692/clinicalneurol.cn-000751. Epub 2015 Sep 11. Japanese.

PMID:
26369373

Supplemental Content

Support Center